Location:
Institut Imagine
24 Boulevard du Montparnasse Paris 14

The aim of the symposium is to bring together the pediatric cancer community to discuss advances in our understanding of the origins and causes of cancer development and the associated therapeutic perspectives. The symposium will address several areas of cancer research, including epidemiological and genetic risk factors, the role of development in tumor initiation, modelising the complex biology of tumors development, and novel therapeutic strategies.

Target audience: physicians, clinicians, basic researchers, biologists, trainees, medical students.

Confirmed speakers are indicated below. The final program will be released soon.

Confirmed speakers

Scott A. Armstrong

Dana-Farber Cancer Institute, USA

Franck Bourdeaut

Institut Curie, Paris

Guillaume Canaud

Hôpital Necker, France

Stephen Chanock

National Cancer Institute, USA

Céline Delloye-Bourgeois

CRCL, France

Jarno Drost

Princess Maxima Center, Netherlands

Friederike Erdmann

IMBEI, Germany

Mariella Filbin

Boston Children’s Hospital, USA

Alain Fischer

Institut Imagine, France

Birgit Geoerger

Gustave Roussy, France

Florent Ginhoux

Gustave Roussy, France

Cédric Maurange

IBDM, France

Katrin Ottersbach

University of Edinburgh, UK

Michael D. Taylor

Texas’s Children’s Hospital, Houston

Abstract submission, oral communications & posters

You would like to present your unpublished work in the symposium?
Submit an abstract before March 14 th, 2024 by e-mail:
symposium2024@programme-pediac.com

You would like to present your unpublished work in the symposium? Submit an abstract
before February 29th, 2024 by e-mail: symposium2024@programme-pediac.com

The scientific committee will evaluate your summary to either present an oral communication of 10 minutes or during the poster session.
Please indicate if you don’t wish to make an oral presentation.

Format : provide a title, list of authors with affiliations indicating the person who will present, a summary of 400 words maximum in English. You may indicate whether your study fits within the following themes: environmental and genetic risk factors, role of ontogeny/development, complex modeling of pediatric cancers, therapeutic perspectives.

A prize will be awarded for the best oral communication.

Program (preliminary) : May 29 th-31 st, 2024

Wednesday May 29 th

12:00-19:00

12:00-13:00

Welcome coffee

13:00-13:35

Keynote lecture: How genetic defects of the immune system predispose to cancer
Alain Fischer, Institut Imagine, Paris, France

Session 1 – Risk factors in childhood cancers

13:40-14:10

Caractérisation des régions de susceptibilité au cancer dans le génome humain
Stephen Chanock, Institut National Cancer, USA

14:10-14:45

Jaqueline Clavel, Hôpital Brousse, Villejuif, France

14:45-15:15

Selected talks

15:15-15:45

Coffee break

15:45-16:20

Childhood cancer incidence and paediatric cancer care during the COVID-19 pandemic in Germany: Any new aetiological insights from the pandemic?
Friederike Erdmann, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Germany

16:20-17:00

Sylvain Latour, Institut Imagine, Paris

17:00-19:00

Poster Session

Jeudi 30 Mai

8:30-18:00

8:30-9:00

Accueil

Session 2 – Déterminants ontogéniques des spécificités des oncogènes pédiatriques

9:00-9:40

Rôle de la cellule d’origine et du microenvironnement fœtal dans le développement de la leucémie pédiatrique
Katrin Ottersbach, University of Edinburgh, Edinburgh, United Kingdom

9:40-10:10

Orateur PEDIAC

10:10-10:40

Communications orales sélectionnées des jeunes chercheurs

10:40-11:10

Discussion informelle / pause café

11:10-11:40

TBD

11:40-12:10

Orateur PEDIAC

12:10-12:50

Développement du système nerveux chez l’embryon et sa dysrégulation dans les cancers pédiatriques
Celine Delloye-Bourgeois, Institut NeuroMyoGène, Lyon, France

12:50-14:00

Déjeuner

Session 3 – Biologie intégrée du développement tumoral

14:00-14:40

Développement et tumorigénèse des tumeurs cérébrales
Michael D. Taylor, Université de Toronto, Toronto, Canada

14:40-15:10

Orateur PEDIAC

15:10-15:40

Communications orales sélectionnées des jeunes chercheurs

15:40-16:10

Discussion informelle / pause café

16:10-16:40

Orateur PEDIAC

16:40-17:20

Caractérisation et modélisation de la complexité du développement des cancers pédiatriques, incluant des approches organoïdes
Jarno Drost, Princess Máxima Center, Utrecht, Pays-Bas

17:20-18:00

Florent Ginhoux

Vendredi 31 Mai

8:30-15:40

8:30-9:00

Accueil

Session 4 : Perspectives thérapeutiques

9:00-9:40

TBD

9:40-10:10

Orateur PEDIAC 

10:10-10:40

Communications orales sélectionnées des jeunes chercheurs

10:40-11:10

Discussion informelle / pause café

11:10-11:40

Orateur PEDIAC

11:40-12:20

Cellule d’origine, mécanisme de transformation de la leucémie myéloïde aiguë et thérapies
Scott A. Armstrong, Dana-Farber Cancer Institute, Boston, USA

12:20-14:00

Lunch

14:00-14:20

Présentation d’Enfants Cancer Santé

14:20-15:00

TBD

15:00-15:40

TBD

15:40 – Clôture du symposium

Registration

Registration fees (3-day admission, including light lunches):
-Regular: 150 €
-Junior (student, post-doc, engineer, 36 years and younger): 50 €

Please fill in the form with the following information:
– Congress name/Workshop: “PEDIAC symposium 2024”
– Beneficiary of invoice: “INSERM DR PARIS IDF SUD”

For general information, please contact symposium2024@programme-pediac.com
For specific information regarding order forms please contact grepa-paris11@inserm.fr

Pratical information

Location: the symposium will be held at Institut Imagine, 24 Boulevard du Montparnasse, Paris 75015. Join us at the Auditorium on the 6 th floor.

Public transport

METRO:
-Line 12, station Falguière
-Lines 10 et 13, station Duroc
-Lines 4, 6, 12 and 13, station Montparnasse
TGV station Montparnasse
BUS Line 89 station Maine – Vaugirard
PLANE take transportation from Charles de Gaulle and Orly airports

Sponsors

We greatly appreciate the support from our sponsors.

Major sponsor

Major sponsor